Osteoporosis diagnosis and monitoring is the core of what this platform serves, through AP spine and proximal femur acquisition, with forearm scanning where the primary sites are unmeasurable. The measurement is clinically usable at a standard that has not materially shifted since the scanner was built. All clinical judgement, including whether an examination is justified and how a result is interpreted, remains with the referring and reporting clinicians, and Medigear.uk supplies configuration and condition detail rather than clinical guidance.
Fracture risk assessment combines the density result with clinical risk factors, and integration with established risk calculation tools is a software matter. Medigear.uk confirms what is enabled on the unit rather than assuming the presence of a feature the platform is capable of supporting.
Vertebral assessment through lateral spine imaging identifies existing vertebral deformity that changes risk categorisation independently of the density figure, and is supported where the licence is enabled. It is among the options most often absent on used systems and is confirmed rather than assumed.
Total body composition work, covering lean and fat distribution, extends the platform into metabolic, nutritional and sports settings. Research and veterinary users also form a meaningful part of the market for densitometers of this generation, where network integration matters less and price matters more. A scanner physically capable of an acquisition still cannot take a clinical referral unlicensed.
Services planning capital cycles should weigh this platform against its likely remaining service window rather than against a new machine's feature list. The measurement will not date. The console, the network position and the parts supply will, and those three together determine how many years of use the price is buying. Medigear.uk supplies each so the calculation can be made properly.



